Ganciclovir Other names: 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine DHPG

Chemical formula: C₉H₁₃N₅O₄  Molecular mass: 255.231 g/mol  PubChem compound: 3454

Therapeutic indications

Ganciclovir is indicated for:

Cytomegalovirus (CMV) disease in immunocompromised patients

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Ganciclovir is indicated in adults and adolescents ≥12 years of age for the treatment of cytomegalovirus (CMV) disease in immunocompromised patients.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prevention of cytomegalovirus (CMV) disease in drug-induced immunosuppression

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Ganciclovir is indicated in adults and adolescents ≥12 years of age for the prevention of CMV disease using pre-emptive therapy in patients with drug-induced immunosuppression (for example following organ transplantation or cancer chemotherapy).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute herpetic keratitis

Population group: only adults (18 years old or older)

Treatment of acute herpetic keratitis (dendritic and geographic ulcers).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Ganciclovir is contraindicated in the following cases:

Lactation

Lactation

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.